Barrington lowered the firm’s price target on Franklin Covey to $45 from $55 and keeps an Outperform rating on the shares following quarterly results. While revenue was roughly in line and adjusted EBITDA was above the high end of guidance, full-year revenue guidance was reduced and adjusted EBITDA is now expected at the low end of the previous guidance range, the firm notes. Barrington acknowledges that the stock will likely underperform, but says it would be a buyer into weakness for long-term capital appreciation.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FC: